Mechanism of polymyxin B resistance in Proteus mirabilis.
The lipids from three types of organisms-a Proteus mirabilis wild type highly resistant to polymyxin B, a polymyxin B-sensitive mutant derived from the wild type, and the wild type grown in the presence of sulfadiazine resulting in phenotypic conversion to polymyxin B sensitivity-were examined to determine the nature of polymyxin B resistance. The phospholipid compositions were nearly identical; each organism contained similar small amounts of N-methyl phosphatidylethanolamine in addition to comparable quantities of phosphatidylethanolamine, phosphatidylglycerol, and cardiolipin. the fatty acid compositions were similar in the exponential phase of growth; in the stationary phase, sulfadiazine markedly inhibited the synthesis of cyclopropane fatty acids. Liposomes prepared from the dried lipids of the three types of organisms were extensively and similarly disrupted by the polymyxin. These findings suggest that polymyxin B resistance in P. mirabilis is determined by the cell envelope which prevents access of the antibiotic to the susceptible lipid target sites.
D002845:Chromatography; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005227:Fatty Acids / Q000032:analysis; D010743:Phospholipids / Q000032:analysis / Q000378:metabolism; D010759:Phosphorus Isotopes; D011113:Polymyxins / Q000494:pharmacology*; D011511:Proteus / Q000187:drug effects* / Q000378:metabolism; D013411:Sulfadiazine / Q000494:pharmacology
D005227:Fatty Acids; D010743:Phospholipids; D010759:Phosphorus Isotopes; D011113:Polymyxins; D013411:Sulfadiazine